ClinicalTrials.Veeva
Menu

Find clinical trials for Pancreatic Cancer in Berlin, BE

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Adenocarcinoma
Cancer
Carcinoma
Colorectal Cancer
Non-Small-Cell Lung Carcinoma
Lung Cancer
Squamous Cell Carcinoma of Head and Neck

Pancreatic Cancer trials near Berlin, BE, DEU:

Evaluation of Efficacy and Safety of Neoadjuvant Treatment With Pamrevlumab in Combination With Chemotherapy (Either Gemcitabine Plus Nab-paclitaxel or FOLFIRINOX) in Participants With Locally Advanced Pancreatic Cancer (LAPIS)

with either gemcitabine plus nab-paclitaxel (G/NP) or FOLFIRINOX in the treatment of participants with locally advanced, unresectable pancreatic...

Active, not recruiting
Pancreatic Cancer Non-resectable
Drug: Pamrevlumab + Gemcitabine + Nab-paclitaxel or Pamrevlumab + FOLFIRINOX
Drug: Placebo + Gemcitabine + Nab-paclitaxel or Placebo + FOLFIRINOX

Phase 3

FibroGen
FibroGen

Berlin, Germany and 89 other locations

Second-line therapy with Nal-IRI after failure gemcitabine/nab-paclitaxel in advanced pancreatic cancer - predictive role of 1st-li...

Active, not recruiting
Locally Advanced Pancreatic Cancer
Metastatic Pancreatic Cancer
Drug: Irinotecan Liposomal Injection [Onivyde]

Phase 3

AIO-Studien

Bad Saarow, Germany and 34 other locations

treatment combinations in participants with metastatic Pancreatic Ductal Adenocarcinoma (PDAC).Two cohorts will be enrolled in parallel in t...

Active, not recruiting
Pancreatic Adenocarcinoma
Drug: Fluorouracil
Drug: RO6874281

Phase 1, Phase 2

Roche
Roche

Berlin, Germany and 26 other locations

or without SBP-101 in subjects previously untreated for metastatic pancreatic ductal adenocarcinoma (PDA), including subjects who have recei...

Enrolling
Pancreatic Cancer Metastatic
Pancreatic Cancer Stage IV
Drug: Gemcitabine
Drug: Nab-paclitaxel

Phase 2, Phase 3

Panbela Therapeutics

Berlin, Germany and 91 other locations

PLATON's pilot-study assesses genomic profiling in gastrointestinal cancer therapy and the frequencies of targetable mutations including Tum...

Enrolling
Oesophageal Cancer
Gallbladder Cancer
Diagnostic Test: FoundationOne®CDx and FoundationOne®Liquid
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest

Berlin, Germany and 42 other locations

This is an interventional, open-label, non-randomised, multicentre, single-arm phase II clinical trial.Eligible patients with hepatic oligometastatic...

Enrolling
Pancreatic Cancer
Metastasis
Drug: nal-irinotecan (nal-iri) (Onyvide), oxaliplatin (ox), 5-fluouracil (5-FU), folinic acid (FA)

Phase 2

University of Cologne

Berlin, Germany and 10 other locations

given to participants. Part C will use the information from Parts A and B to see if SGN-BB228 is safe and if it works to treat solid tumor cancers...

Enrolling
Non-small Cell Lung Cancer
Pancreatic Neoplasms
Drug: SGN-BB228

Phase 1

Seagen
Seagen

Berlin, Other, Germany and 18 other locations

efficacy of AZD9574 individually and in combination with anti-cancer agents in 490 participants with advanced cancer that has recur...

Enrolling
Advanced Solid Malignancies
Drug: AZD9574
Drug: Temozolomide

Phase 1, Phase 2

AstraZeneca
AstraZeneca

Berlin, Germany and 30 other locations

This is an open-label, multicenter, global Phase 2 basket study of entrectinib (RXDX-101) for the treatment of patients with solid tumors that harbor...

Active, not recruiting
Breast Cancer
Papillary Thyroid Cancer
Drug: Entrectinib

Phase 2

Roche
Roche

Berlin, Germany and 122 other locations

liposome injection in combination with other approved drugs used for cancer therapy, namely 5 fluorouracil/leucovorin (5FU/LV) plus oxalipla ...

Active, not recruiting
Metastatic Adenocarcinoma of the Pancreas
Drug: Leucovorin
Drug: Gemcitabine

Phase 3

Ipsen
Ipsen

Berlin, Germany and 199 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems